The scientists aim to better understand a phenomenon where the severity of effects of a particular genetic mutation differs among individuals who carry it.
The Israeli institute will share its expertise on translating research into commercially viable applications with the goal of advancing personalized medicine.
The researchers applied their so-called GWAX approach to study 12 common diseases in almost 120,000 individuals, confirming known and uncovering novel disease risk loci.
A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.
